For the first time in 13 years, the Food and Medicine Administration has approved the weight-loss drug Belviq in the United States. At least one weight-related condition must exist for this drug to be approved for treatment in obese adults (BMI of 30 kg/m2 or larger) and overweight adults (BMI...

Contrave (naltrexone and bupropion) one of the most popular prescription drugs used to treat chronic (long-term) obesity in individuals with at least one other weight-related disorder. It comprises naltrexone and bupropion. Naltrexone is an opiate antagonist. Antidepressant Bupropion Contrave's components target the brain's hunger and reward centers. They curb hunger...